Most of the pharmaceutical companies are investing in the development of novel drugs and devices. The pharmaceutical industry, in particular, is R&D-intensive. Pharmaceutical companies invest in R&D to deliver high quality and innovative products to the market. The trend suggests that the top pharma companies are increasing their R&D efficiencies by increasing investments for assured returns in the long term and through collaborative R&D efforts. Increase in pharmaceutical R&D has resulted in a sharp increase in the number of cell & gene therapy candidates under development. This has made it necessary to outsource manufacturing services to develop cost-effective and efficient cell & gene therapies, which drives the central lab market.
The global Medical Central Lab market is projected to reach US$ 1491.9 million in 2029, increasing from US$ 1125.3 million in 2022, with the CAGR of 4.3% during the period of 2023 to 2029.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Medical Central Lab market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
ACM Global Central Lab
Barc Lab (Cerba Research)
Bioscientia (Sonic Healthcare)
Celerion
CIRION BioPharma Research
Clinical Reference Laboratory
Eurofins Central Laboratory
Frontage Laboratories, Inc.
ICON Central Labs.
INTERLAB Central Lab Services
InVitro International
Lab Corp/Covance
LabConnect
Medpace
MLM Medical Labs GmbH
PPD
Q² Solutions
Synevo Central Lab
Segment by Type
Genetic Services
Biomarker Services
Microbiology Services
Anatomic Pathology / Histology
Specimen Management and Storage
Special Chemistry Services
Clinical Research and Trial Services
Segment by Application
Pharmaceutical Companies
Biotechnology Companies
Academic and Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Medical Central Lab report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Âé¶¹Ô´´ Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Âé¶¹Ô´´ Conclusions
Chapter 13: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global Medical Central Lab Âé¶¹Ô´´ Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Genetic Services
1.2.3 Biomarker Services
1.2.4 Microbiology Services
1.2.5 Anatomic Pathology / Histology
1.2.6 Specimen Management and Storage
1.2.7 Special Chemistry Services
1.2.8 Clinical Research and Trial Services
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global Medical Central Lab Âé¶¹Ô´´ Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical Companies
1.3.3 Biotechnology Companies
1.3.4 Academic and Research Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Medical Central Lab Âé¶¹Ô´´ Perspective (2018-2029)
2.2 Medical Central Lab Growth Trends by Region
2.2.1 Global Medical Central Lab Âé¶¹Ô´´ Size by Region: 2018 VS 2022 VS 2029
2.2.2 Medical Central Lab Historic Âé¶¹Ô´´ Size by Region (2018-2023)
2.2.3 Medical Central Lab Forecasted Âé¶¹Ô´´ Size by Region (2024-2029)
2.3 Medical Central Lab Âé¶¹Ô´´ Dynamics
2.3.1 Medical Central Lab Industry Trends
2.3.2 Medical Central Lab Âé¶¹Ô´´ Drivers
2.3.3 Medical Central Lab Âé¶¹Ô´´ Challenges
2.3.4 Medical Central Lab Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Top Medical Central Lab Players by Revenue
3.1.1 Global Top Medical Central Lab Players by Revenue (2018-2023)
3.1.2 Global Medical Central Lab Revenue Âé¶¹Ô´´ Share by Players (2018-2023)
3.2 Global Medical Central Lab Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Medical Central Lab Revenue
3.4 Global Medical Central Lab Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global Medical Central Lab Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medical Central Lab Revenue in 2022
3.5 Medical Central Lab Key Players Head office and Area Served
3.6 Key Players Medical Central Lab Product Solution and Service
3.7 Date of Enter into Medical Central Lab Âé¶¹Ô´´
3.8 Mergers & Acquisitions, Expansion Plans
4 Medical Central Lab Breakdown Data by Type
4.1 Global Medical Central Lab Historic Âé¶¹Ô´´ Size by Type (2018-2023)
4.2 Global Medical Central Lab Forecasted Âé¶¹Ô´´ Size by Type (2024-2029)
5 Medical Central Lab Breakdown Data by Application
5.1 Global Medical Central Lab Historic Âé¶¹Ô´´ Size by Application (2018-2023)
5.2 Global Medical Central Lab Forecasted Âé¶¹Ô´´ Size by Application (2024-2029)
6 North America
6.1 North America Medical Central Lab Âé¶¹Ô´´ Size (2018-2029)
6.2 North America Medical Central Lab Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Medical Central Lab Âé¶¹Ô´´ Size by Country (2018-2023)
6.4 North America Medical Central Lab Âé¶¹Ô´´ Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Medical Central Lab Âé¶¹Ô´´ Size (2018-2029)
7.2 Europe Medical Central Lab Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Medical Central Lab Âé¶¹Ô´´ Size by Country (2018-2023)
7.4 Europe Medical Central Lab Âé¶¹Ô´´ Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Medical Central Lab Âé¶¹Ô´´ Size (2018-2029)
8.2 Asia-Pacific Medical Central Lab Âé¶¹Ô´´ Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Medical Central Lab Âé¶¹Ô´´ Size by Region (2018-2023)
8.4 Asia-Pacific Medical Central Lab Âé¶¹Ô´´ Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Medical Central Lab Âé¶¹Ô´´ Size (2018-2029)
9.2 Latin America Medical Central Lab Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Medical Central Lab Âé¶¹Ô´´ Size by Country (2018-2023)
9.4 Latin America Medical Central Lab Âé¶¹Ô´´ Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Medical Central Lab Âé¶¹Ô´´ Size (2018-2029)
10.2 Middle East & Africa Medical Central Lab Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Medical Central Lab Âé¶¹Ô´´ Size by Country (2018-2023)
10.4 Middle East & Africa Medical Central Lab Âé¶¹Ô´´ Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ACM Global Central Lab
11.1.1 ACM Global Central Lab Company Detail
11.1.2 ACM Global Central Lab Business Overview
11.1.3 ACM Global Central Lab Medical Central Lab Introduction
11.1.4 ACM Global Central Lab Revenue in Medical Central Lab Business (2018-2023)
11.1.5 ACM Global Central Lab Recent Development
11.2 Barc Lab (Cerba Research)
11.2.1 Barc Lab (Cerba Research) Company Detail
11.2.2 Barc Lab (Cerba Research) Business Overview
11.2.3 Barc Lab (Cerba Research) Medical Central Lab Introduction
11.2.4 Barc Lab (Cerba Research) Revenue in Medical Central Lab Business (2018-2023)
11.2.5 Barc Lab (Cerba Research) Recent Development
11.3 Bioscientia (Sonic Healthcare)
11.3.1 Bioscientia (Sonic Healthcare) Company Detail
11.3.2 Bioscientia (Sonic Healthcare) Business Overview
11.3.3 Bioscientia (Sonic Healthcare) Medical Central Lab Introduction
11.3.4 Bioscientia (Sonic Healthcare) Revenue in Medical Central Lab Business (2018-2023)
11.3.5 Bioscientia (Sonic Healthcare) Recent Development
11.4 Celerion
11.4.1 Celerion Company Detail
11.4.2 Celerion Business Overview
11.4.3 Celerion Medical Central Lab Introduction
11.4.4 Celerion Revenue in Medical Central Lab Business (2018-2023)
11.4.5 Celerion Recent Development
11.5 CIRION BioPharma Research
11.5.1 CIRION BioPharma Research Company Detail
11.5.2 CIRION BioPharma Research Business Overview
11.5.3 CIRION BioPharma Research Medical Central Lab Introduction
11.5.4 CIRION BioPharma Research Revenue in Medical Central Lab Business (2018-2023)
11.5.5 CIRION BioPharma Research Recent Development
11.6 Clinical Reference Laboratory
11.6.1 Clinical Reference Laboratory Company Detail
11.6.2 Clinical Reference Laboratory Business Overview
11.6.3 Clinical Reference Laboratory Medical Central Lab Introduction
11.6.4 Clinical Reference Laboratory Revenue in Medical Central Lab Business (2018-2023)
11.6.5 Clinical Reference Laboratory Recent Development
11.7 Eurofins Central Laboratory
11.7.1 Eurofins Central Laboratory Company Detail
11.7.2 Eurofins Central Laboratory Business Overview
11.7.3 Eurofins Central Laboratory Medical Central Lab Introduction
11.7.4 Eurofins Central Laboratory Revenue in Medical Central Lab Business (2018-2023)
11.7.5 Eurofins Central Laboratory Recent Development
11.8 Frontage Laboratories, Inc.
11.8.1 Frontage Laboratories, Inc. Company Detail
11.8.2 Frontage Laboratories, Inc. Business Overview
11.8.3 Frontage Laboratories, Inc. Medical Central Lab Introduction
11.8.4 Frontage Laboratories, Inc. Revenue in Medical Central Lab Business (2018-2023)
11.8.5 Frontage Laboratories, Inc. Recent Development
11.9 ICON Central Labs.
11.9.1 ICON Central Labs. Company Detail
11.9.2 ICON Central Labs. Business Overview
11.9.3 ICON Central Labs. Medical Central Lab Introduction
11.9.4 ICON Central Labs. Revenue in Medical Central Lab Business (2018-2023)
11.9.5 ICON Central Labs. Recent Development
11.10 INTERLAB Central Lab Services
11.10.1 INTERLAB Central Lab Services Company Detail
11.10.2 INTERLAB Central Lab Services Business Overview
11.10.3 INTERLAB Central Lab Services Medical Central Lab Introduction
11.10.4 INTERLAB Central Lab Services Revenue in Medical Central Lab Business (2018-2023)
11.10.5 INTERLAB Central Lab Services Recent Development
11.11 InVitro International
11.11.1 InVitro International Company Detail
11.11.2 InVitro International Business Overview
11.11.3 InVitro International Medical Central Lab Introduction
11.11.4 InVitro International Revenue in Medical Central Lab Business (2018-2023)
11.11.5 InVitro International Recent Development
11.12 Lab Corp/Covance
11.12.1 Lab Corp/Covance Company Detail
11.12.2 Lab Corp/Covance Business Overview
11.12.3 Lab Corp/Covance Medical Central Lab Introduction
11.12.4 Lab Corp/Covance Revenue in Medical Central Lab Business (2018-2023)
11.12.5 Lab Corp/Covance Recent Development
11.13 LabConnect
11.13.1 LabConnect Company Detail
11.13.2 LabConnect Business Overview
11.13.3 LabConnect Medical Central Lab Introduction
11.13.4 LabConnect Revenue in Medical Central Lab Business (2018-2023)
11.13.5 LabConnect Recent Development
11.14 Medpace
11.14.1 Medpace Company Detail
11.14.2 Medpace Business Overview
11.14.3 Medpace Medical Central Lab Introduction
11.14.4 Medpace Revenue in Medical Central Lab Business (2018-2023)
11.14.5 Medpace Recent Development
11.15 MLM Medical Labs GmbH
11.15.1 MLM Medical Labs GmbH Company Detail
11.15.2 MLM Medical Labs GmbH Business Overview
11.15.3 MLM Medical Labs GmbH Medical Central Lab Introduction
11.15.4 MLM Medical Labs GmbH Revenue in Medical Central Lab Business (2018-2023)
11.15.5 MLM Medical Labs GmbH Recent Development
11.16 PPD
11.16.1 PPD Company Detail
11.16.2 PPD Business Overview
11.16.3 PPD Medical Central Lab Introduction
11.16.4 PPD Revenue in Medical Central Lab Business (2018-2023)
11.16.5 PPD Recent Development
11.17 Q² Solutions
11.17.1 Q² Solutions Company Detail
11.17.2 Q² Solutions Business Overview
11.17.3 Q² Solutions Medical Central Lab Introduction
11.17.4 Q² Solutions Revenue in Medical Central Lab Business (2018-2023)
11.17.5 Q² Solutions Recent Development
11.18 Synevo Central Lab
11.18.1 Synevo Central Lab Company Detail
11.18.2 Synevo Central Lab Business Overview
11.18.3 Synevo Central Lab Medical Central Lab Introduction
11.18.4 Synevo Central Lab Revenue in Medical Central Lab Business (2018-2023)
11.18.5 Synevo Central Lab Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
ACM Global Central Lab
Barc Lab (Cerba Research)
Bioscientia (Sonic Healthcare)
Celerion
CIRION BioPharma Research
Clinical Reference Laboratory
Eurofins Central Laboratory
Frontage Laboratories, Inc.
ICON Central Labs.
INTERLAB Central Lab Services
InVitro International
Lab Corp/Covance
LabConnect
Medpace
MLM Medical Labs GmbH
PPD
Q² Solutions
Synevo Central Lab
Ìý
Ìý
*If Applicable.